DNA sequence analysis is a key component of the FDA's structural characterization (identity) requirement for gene transfer products. Other components include restriction mapping, QPCR, and Southern blot analysis. SeqWright offers these assays as GLP-level services in a quality controlled, regulated laboratory environment for IND sponsors and other investigators requiring this high-level of service.

For more information about compliance, read about our Regulatory Compliance

Full-length DNA sequence analysis
Restriction digest mapping
PCR mapping
Copy number determination by QPCR (learn more)
Insert site number by Southern blot analysis
Full Annotation (ORFs, Pfam/CoG/BLAST, toxicity)
21 CFR 58 compliant (GLP)
Project reports signed by an SQA-registered Quality Assurance Unit (QAU)
Custom vector construction available
References available